Drug intelligence / Profile preview

ketoprofen + isoniazid

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous, Topical, Rectal
01

Overview

This is a combination drug consisting of ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID), and isoniazid, an antibiotic primarily used to treat tuberculosis. Ketoprofen acts by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis and thereby decreasing inflammation, pain, and fever. Isoniazid works as a prodrug activated by the mycobacterial enzyme KatG; it generates reactive oxygen species that disrupt the mycobacterial cell wall, making it bactericidal against replicating Mycobacterium tuberculosis. The combination of these two drugs does not have a unique clinical indication or established use together but may be considered in rare cases where both anti-inflammatory and antimycobacterial effects are needed. Coadministration should be approached with caution due to potential additive hepatotoxicity[1][5].

02

Targets

InhAPGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)FAS-I (Mycobacterial fatty acid synthase I complex)

Beyond the preview

Go deeper on ketoprofen + isoniazid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ketoprofen + isoniazid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call